ArticleBMJ open2018

Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink.

John-Michael Gamble et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.